Impacts of prenatal diagnosis of congenital heart diseases on outcomes
- PMID: 34584895
- PMCID: PMC8429871
- DOI: 10.21037/tp-20-267
Impacts of prenatal diagnosis of congenital heart diseases on outcomes
Abstract
Prenatal diagnosis of congenital heart diseases (CHD) is increasingly performed in developed countries. Still, the current impacts of prenatal diagnosis on fetal and neonatal outcomes remains unclear or contradictory. We will review here the different consequences of prenatal screening and of fetal echocardiography on different categories of outcomes. Increasing detection may lead to a reduced birth incidence of severe complex CHD through a high rate of termination of pregnancy but this trend is not universal. Conversely, one of the main impacts of prenatal diagnosis is to optimize perinatal care and to improve hard outcomes such as mortality. Indeed, decrease of neonatal mortality is inconsistently observed in transposition of the great arteries and is not shown in other defects. The reduction of perinatal morbidity is a new end-point to scrutinize but how to examine this impact is controversial in the neonatal period. The influence of the reduction of neonatal distress may modify neurodevelopmental outcomes and quality of survival. The risk stratification after a prenatal diagnosis of CHD helps to optimize the timing, mode, and site of management with the aim to improve outcomes. The anticipated care is tailored according to the type of CHD and expected initial physiology. However, the imprecision of prenatal diagnosis even in expert centers hampers this logical outcome. Prediction of the type of repair is theoretically possible but remains challenging in defects such as double outlet right ventricles or pulmonary atresia with ventricular septal defect. The cost of prenatal diagnosis or of its absence is still a matter of debate and policies have to be tailored to regional health systems. Finally, the impact on parents and siblings is a rarely explored outcome. Screening and echography of fetal heart are currently performed in developed countries but it is still too early to talk about fetal cardiology.
Keywords: Prenatal diagnosis; cost-effectiveness; fetus; morbidity; mortality.
2021 Translational Pediatrics. All rights reserved.
Conflict of interest statement
Conflicts of Interest: The author is completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tp-20-267). The series “Pre-natal Diagnosis in Congenital Heart Defects” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.
Figures

Similar articles
-
Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983-2000: a population-based evaluation.Pediatrics. 2005 Jan;115(1):95-101. doi: 10.1542/peds.2004-0516. Pediatrics. 2005. PMID: 15629987
-
Live-Born Major Congenital Heart Disease in Denmark: Incidence, Detection Rate, and Termination of Pregnancy Rate From 1996 to 2013.JAMA Cardiol. 2018 Sep 1;3(9):829-837. doi: 10.1001/jamacardio.2018.2009. JAMA Cardiol. 2018. PMID: 30027209 Free PMC article.
-
Fetal cardiology: changing the definition of critical heart disease in the newborn.J Perinatol. 2016 Aug;36(8):575-80. doi: 10.1038/jp.2016.20. Epub 2016 Mar 10. J Perinatol. 2016. PMID: 26963427 Review.
-
Effectiveness of prenatal diagnosis of congenital heart defects in South Australia: a population analysis 1999-2003.Aust N Z J Obstet Gynaecol. 2008 Dec;48(6):559-63. doi: 10.1111/j.1479-828X.2008.00915.x. Aust N Z J Obstet Gynaecol. 2008. PMID: 19133043
-
Prenatal diagnosis of congenital heart defects: echocardiography.Transl Pediatr. 2021 Aug;10(8):2210-2224. doi: 10.21037/tp-20-164. Transl Pediatr. 2021. PMID: 34584892 Free PMC article. Review.
Cited by
-
Keeping the Ductus Arteriosus Patent: Current Strategy and Perspectives.Diagnostics (Basel). 2025 Jan 21;15(3):241. doi: 10.3390/diagnostics15030241. Diagnostics (Basel). 2025. PMID: 39941172 Free PMC article. Review.
-
Preoperative Care of Neonates With Congenital Heart Disease.Neonatal Netw. 2022 Jul 1;41(4):200-210. doi: 10.1891/NN-2021-0028. Neonatal Netw. 2022. PMID: 35840337 Free PMC article.
-
Impact of a Standardised Fetal Cardiac Screening Programme on Antenatal Detection Rates of Transposition of the Great Arteries.Australas J Ultrasound Med. 2025 Jun 13;28(3):e70004. doi: 10.1002/ajum.70004. eCollection 2025 Aug. Australas J Ultrasound Med. 2025. PMID: 40519706
-
Assessment of NanoString technology as a tool for profiling circulating miRNA in maternal blood during pregnancy.Extracell Vesicles Circ Nucl Acids. 2024 Sep 5;5(3):471-496. doi: 10.20517/evcna.2024.38. eCollection 2024. Extracell Vesicles Circ Nucl Acids. 2024. PMID: 39697629 Free PMC article.
-
Looking at a baby's heart through the lens of the mother's blood.EMBO Mol Med. 2023 Dec 7;15(12):e18680. doi: 10.15252/emmm.202318680. Epub 2023 Oct 16. EMBO Mol Med. 2023. PMID: 37840430 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources